PL2569417T3 - Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania - Google Patents
Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowaniaInfo
- Publication number
- PL2569417T3 PL2569417T3 PL11728406T PL11728406T PL2569417T3 PL 2569417 T3 PL2569417 T3 PL 2569417T3 PL 11728406 T PL11728406 T PL 11728406T PL 11728406 T PL11728406 T PL 11728406T PL 2569417 T3 PL2569417 T3 PL 2569417T3
- Authority
- PL
- Poland
- Prior art keywords
- isolating
- methods
- same
- renal cells
- isolated populations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33420610P | 2010-05-13 | 2010-05-13 | |
| US201161457613P | 2011-05-02 | 2011-05-02 | |
| EP11728406.7A EP2569417B1 (en) | 2010-05-13 | 2011-05-12 | Isolated populations of adult renal cells and methods of isolating and using same |
| PCT/IL2011/000376 WO2011141914A1 (en) | 2010-05-13 | 2011-05-12 | Isolated populations of adult renal cells and methods of isolating and using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2569417T3 true PL2569417T3 (pl) | 2018-12-31 |
Family
ID=44515147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11728406T PL2569417T3 (pl) | 2010-05-13 | 2011-05-12 | Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20130059325A1 (pl) |
| EP (1) | EP2569417B1 (pl) |
| CA (1) | CA2799307C (pl) |
| ES (1) | ES2672918T3 (pl) |
| PL (1) | PL2569417T3 (pl) |
| WO (1) | WO2011141914A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2401363B1 (en) | 2009-02-26 | 2018-08-22 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Methods of reprogramming renal cells |
| RU2016100232A (ru) | 2013-06-14 | 2017-07-17 | Дзе Юниверсити Оф Квинсленд | Почечные клетки-предшественники |
| WO2015134610A1 (en) * | 2014-03-06 | 2015-09-11 | Yale University | Methods for treating diabetic nephropathy |
| WO2017041041A1 (en) * | 2015-09-03 | 2017-03-09 | The Brigham And Women's Hospital, Inc. | Three-dimensional differentiation of epiblast spheroids to kidney organoids models stage-specific epithelial physiology, morphogenesis, and disease |
| AU2017335841A1 (en) | 2016-09-28 | 2019-04-04 | Organovo, Inc. | Use of engineered renal tissues in assays |
| JP6995112B2 (ja) | 2017-04-06 | 2022-02-04 | 日機装株式会社 | 細胞の培養方法及び細胞支持複合体の製造方法 |
| WO2019181920A1 (ja) | 2018-03-22 | 2019-09-26 | 日機装株式会社 | 細胞の培養方法、細胞支持複合体の製造方法、培養細胞および細胞支持複合体 |
| WO2020223660A1 (en) * | 2019-05-02 | 2020-11-05 | Timothy Bertram | Treatment of kidney disease in subjects with kidney and/or urinary tract anomalies |
| EP4229181A4 (en) * | 2020-10-19 | 2024-10-02 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | URINE-DERIVED EPITHELIAL CELL CULTURES, NEPHROSPHEROIDS DERIVED THEREFROM AND METHODS OF PRODUCTION AND USE THEREOF |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US6150164A (en) | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| US6235551B1 (en) | 1997-12-31 | 2001-05-22 | Micron Technology, Inc. | Semiconductor device including edge bond pads and methods |
| US6458588B1 (en) | 2001-01-31 | 2002-10-01 | The General Hospital Corporation | Renal stem cells and uses thereof |
| US20040014209A1 (en) | 2002-01-23 | 2004-01-22 | Lassar Andrew B. | Compositions and methods for modulating cell differentiation |
| JP2005050666A (ja) | 2003-07-28 | 2005-02-24 | Tokai Rubber Ind Ltd | 燃料電池用ホース材料およびそれを用いてなる燃料電池用ホース |
| US20070031966A1 (en) | 2005-07-18 | 2007-02-08 | Regents Of The University Of Michigan | Renal progenitor cells from embryonic stem cells |
| US7776592B2 (en) | 2005-08-31 | 2010-08-17 | Stc.Unm | Human renal stem cells |
| TW200925513A (en) | 2007-12-11 | 2009-06-16 | Prodisc Technology Inc | LED lamp structure for reducing multiple shadows |
| EP2401363B1 (en) | 2009-02-26 | 2018-08-22 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Methods of reprogramming renal cells |
-
2011
- 2011-05-12 EP EP11728406.7A patent/EP2569417B1/en active Active
- 2011-05-12 US US13/697,531 patent/US20130059325A1/en not_active Abandoned
- 2011-05-12 ES ES11728406.7T patent/ES2672918T3/es active Active
- 2011-05-12 PL PL11728406T patent/PL2569417T3/pl unknown
- 2011-05-12 WO PCT/IL2011/000376 patent/WO2011141914A1/en not_active Ceased
- 2011-05-12 CA CA2799307A patent/CA2799307C/en not_active Expired - Fee Related
-
2018
- 2018-07-26 US US16/045,784 patent/US10870834B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10870834B2 (en) | 2020-12-22 |
| EP2569417B1 (en) | 2018-04-18 |
| CA2799307A1 (en) | 2011-11-17 |
| ES2672918T3 (es) | 2018-06-18 |
| WO2011141914A1 (en) | 2011-11-17 |
| EP2569417A1 (en) | 2013-03-20 |
| US20130059325A1 (en) | 2013-03-07 |
| CA2799307C (en) | 2019-07-02 |
| US20180346882A1 (en) | 2018-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2569417T3 (pl) | Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania | |
| EP2526183A4 (en) | Magnetic separation of rare cells | |
| IL226156A0 (en) | Modular electrochemical systems and methods | |
| IL225635A0 (en) | Supplement for cell culture | |
| GB201119888D0 (en) | Methods of receiving and receivers | |
| EP2606123A4 (en) | METHOD OF GENERATING OLIGOD DROCYTES AND CELL POPULATIONS THEREWITH | |
| HUE053232T2 (hu) | Sejtek és eljárások ramnolipidek elõállítására | |
| CA3252526A1 (en) | Induction of pluripotent cells | |
| SI2683815T1 (sl) | Gensko modificirana celica in postopek za uporabo omenjene celice | |
| ZA201207616B (en) | Cell balancing system | |
| IL216043A0 (en) | Isolated populations of renal stem cells and methods of isolating and using same | |
| EP2582910A4 (en) | SYSTEMS AND METHODS FOR ISOLATING CURRENT PASSAGE TO DRILLING LOADS | |
| IL233355A0 (en) | Methods for isolating (4-chloro-2-fluoro-3-converted-phenyl)boronates and methods for using them | |
| IL223017A0 (en) | Isolated populations of adult renal cells and methods of isolating and using same | |
| GB2496502B (en) | Methods of receiving and receivers | |
| GB2492495B (en) | Methods of receiving and receivers | |
| GB2503761B (en) | Modular interface systems and methods | |
| HK1196395A (en) | Mesenchymal stromal cell populations and methods of making same | |
| IL221023A0 (en) | Magnetic separation of rare cells | |
| GB201002075D0 (en) | Isolation of cells | |
| TWM389392U (en) | Structural improvement of charger | |
| HU1000558D0 (en) | Separator and separation method | |
| TWM389356U (en) | Structural improvement of battery set | |
| GB2495021B (en) | Enrichment of isotopes using substrates | |
| GB201021699D0 (en) | Assay of functional cell viability |